Nutrition & Care
In the Nutrition & Care segment – consisting of the Care Chemicals and Nutrition & Health divisions – we serve the growing and increasingly sophisticated demands for fast-moving consumer goods. Our customers include food and feed producers as well as the pharmaceutical, cosmetics, detergent and cleaner industries. We strive to expand our position as a leading provider of ingredients and solutions for consumer applications in the areas of nutrition, home and personal care. Our goal is to drive organic growth by focusing on emerging markets, new business models and sustainability trends in consumer markets, supported by targeted acquisitions.
Divisions

BASF has launched three digital virtual assistants to cover key customer needs:
▪ ZoomLab™
▪ RegXcellence™
▪ MyProductWorld
ZoomLab™ predicts optimized formulations of pharmaceutical drugs faster and more precisely than previously possible. Finding the right combination between the active pharmaceutical ingredient and excipients is very time and resource-consuming.
RegXcellence™ makes registration processes seamless, saving customers time and costs during important milestones such as qualification of ingredients and market authorization of their drugs.
The third virtual assistant, MyProductWorld, provides the customer with a comprehensive list of excipients and API solutions to help them find what they need in one convenient interactive platform.

Factors influencing sales
EBIT before special items


Million € | 2019 | 2018 |
Sales to third parties | 6,075 | 5,940 |
Share of total BASF sales (%) | 10 | 10 |
of which Care Chemicals |
4,118 | 4,244 |
Nutrition & Health |
1,957 | 1,696 |
Income from operations before depreciation and amortization (EBITDA) before special items | 1,214 | 1,128 |
Income from operations before depreciation and amortization (EBITDA) | 1,189 | 1,107 |
EBITDA margin (%) | 20 | 19 |
Income from operations (EBIT) before special items | 793 | 736 |
EBIT before special items margin (%) | 13 | 12 |
Income from operations (EBIT) | 644 | 715 |
EBIT margin (%) | 11 | 12 |
Return on capital employed (ROCE) (%) | 10.0 | 11. 8 |